Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 992

    1.

    Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.

    Vittinghoff E, Shlipak MG, Varosy PD, Furberg CD, Ireland CC, Khan SS, Blumenthal R, Barrett-Connor E, Hulley S; Heart and Estrogen/progestin Replacement Study Research Group.

    Ann Intern Med. 2003 Jan 21;138(2):81-9.PMID: 12529088 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

    JAMA. 1998 Aug 19;280(7):605-13.PMID: 9718051 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

    JAMA. 2000 Apr 12;283(14):1845-52.PMID: 10770146 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.

    Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S.

    JAMA. 1997 Apr 23-30;277(16):1281-6.PMID: 9109465 [PubMed - indexed for MEDLINE]Related articles

    5.

    Summaries for patients. Risk factors and treatment in women with coronary artery disease.

    [No authors listed]

    Ann Intern Med. 2003 Jan 21;138(2):I10. No abstract available. PMID: 12529114 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064. PMID: 12090862 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).

    Reiner Z, Mihatov S, Milicić D, Bergovec M, Planinc D; TASPIC-CRO Study Group Investigators.

    Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):646-54.PMID: 16874158 [PubMed - indexed for MEDLINE]Related articles

    8.

    Predictors of heart failure among women with coronary disease.

    Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG.

    Circulation. 2004 Sep 14;110(11):1424-30. Epub 2004 Sep 7.PMID: 15353499 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Secondary prevention in chronic coronary heart disease]

    Hunziker P, Bertel O.

    Schweiz Med Wochenschr. 1997 Feb 15;127(7):254-60. German. PMID: 9157530 [PubMed - indexed for MEDLINE]Related articles

    10.

    Secondary prevention of coronary heart disease in older patients after the national service framework: population based study.

    Ramsay SE, Whincup PH, Lawlor DA, Papacosta O, Lennon LT, Thomas MC, Ebrahim S, Morris RW.

    BMJ. 2006 Jan 21;332(7534):144-5. Epub 2006 Jan 9.PMID: 16401630 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A prospective study of aspirin use and primary prevention of cardiovascular disease in women.

    Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH.

    JAMA. 1991 Jul 24-31;266(4):521-7.PMID: 2061978 [PubMed - indexed for MEDLINE]Related articles

    12.

    Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

    Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD; Heart and Estrogen/Progestin Replacement Study (HERS) Investigators.

    Am J Kidney Dis. 2004 Jan;43(1):37-44.PMID: 14712425 [PubMed - indexed for MEDLINE]Related articles

    13.

    Management of older persons after myocardial infarction.

    Aronow WS.

    J Am Geriatr Soc. 1998 Nov;46(11):1459-68. Review.PMID: 9809771 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events.

    Lancet. 2001 Mar 31;357(9261):995-1001.PMID: 11293642 [PubMed - indexed for MEDLINE]Related articles

    15.

    Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.

    Grodstein F, Manson JE, Stampfer MJ.

    Ann Intern Med. 2001 Jul 3;135(1):1-8.PMID: 11434726 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

    Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ.

    Ann Intern Med. 2000 Dec 19;133(12):933-41.PMID: 11119394 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    ESC Population Studies Lecture 1996. Cardiovascular monitoring of a city over 30 years.

    Wilhelmsen L.

    Eur Heart J. 1997 Aug;18(8):1220-30.PMID: 9458414 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The incidence of unrecognized myocardial infarction in women with coronary heart disease.

    Shlipak MG, Elmouchi DA, Herrington DM, Lin F, Grady D, Hlatky MA; Heart and Estrogen/progestin Replacement Study Research Group.

    Ann Intern Med. 2001 Jun 5;134(11):1043-7.PMID: 11388817 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.

    Nair GV, Chaput LA, Vittinghoff E, Herrington DM; Heart and Estrogen/Progestin Replacement Study Investigators.

    Chest. 2005 May;127(5):1498-506.PMID: 15888820 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.

    Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L.

    J Vasc Surg. 2005 Sep;42(3):456-64; discussion 464-5.PMID: 16171587 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data